| 标题 |
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy |
| 网址 | |
| DOI |
10.1136/jitc-2024-010294
doi
|
| 其它 |
期刊:Journal for ImmunoTherapy of Cancer 作者:Harry D. Bear; Xiaoyan Deng; Dipankar Bandyopadhyay; Michael O. Idowu; Taylor M. Jenkins; et al 出版日期:2025-02-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)